Wednesday, 21 Aug 2019

You are here

Maternal RA Increases Offspring Risk of Autoimmune Disorders

A Danish population study suggests that fetal exposure to maternal rheumatoid arthritis (RA) results in an increased offspring risk of thyroid disease, epilepsy and RA, compared to children born to mothers without RA.

Researchers examined a possible association between maternal RA and 15 select chronic diseases in the offspring in a national cohort study using Danish health registries. They examined 2106 children born to RA women (exposed) between 1989 and 2013 and compared outcomes to 1,378,539 children born by women without RA (unexposed).

Exposure to maternal RA resulted in an increased offspring risk for:

  • Thyroid diseases (hazard ratio [HR] 2.19; 95% confidence interval [95% CI] 1.14–4.21)
  • Epilepsy (HR 1.61; 95% CI 1.16–2.25)
  • RA 2.89 (HR 95% CI 2.06–4.05).

Increased but not significant were the odds of developing anxiety, personality disorders and chronic lung disease, including asthma (HR range of 1.15–1.16).

This registry, population-based analysis suggests in utero exposure to maternal RA is associated with an increased risk of select autoimmune conditions, including RA.  While there was a nearly 2-3 fold risk of these autoimmune conditions the overall individual risk still remained quite low (RA exposed risk to offspring was 1.6% compared with 0.7% in unexposed).

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Good Pregnancy Outcomes for DMARD Exposed JIA Patients

A study of pregnancy outcomes in 98 women with juvenile idiopathic arthritis (JIA) who were exposed to DMARDs shows no increased risk of major adverse pregnancy outcomes.

A total of 152 pregnancies in 98 women with JIA and 39 pregnancies involving 21 male patients as partners were reviewed. The majority had a polyarticular JIA (61%). The average age at first pregnancy was 24.1 years, and their mean disease duration was 13.8 years.

Autoantibodies Don't Disappear With Remission in RA

Immunologic remission in rheumatoid arthritis, defined as the disappearance of anti-citrullinated protein antibodies and rheumatoid factor, was seen infrequently among patients achieving sustained clinical remission and did not correlate with the disappearance of symptoms, a long-term Dutch study found.

Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease

Serologic testing is the principal means of laboratory diagnosis of Lyme disease. Current recommendations include using a sensitive enzyme immunoassay (EIA) or immunofluorescence assay, followed by a western immunoblot assay for specimens yielding positive or equivocal results. On July 29, 2019, the Food and Drug Administration cleared several Lyme disease serologic assays with new indications for use, allowing for an EIA rather than western immunoblot assay as the second test in a Lyme disease testing algorithm. Thus, serologic assays that utilize a second EIA in place of western immunoblot assay are acceptable alternatives for the serologic diagnosis of Lyme disease.

Trends in Inflammatory Arthritis Care in Germany

The German National Database (NDB) has reviewed their experience in the care and quality of life of inflammatory rheumatic disease patients snce 1993, showing improved use of metrics, improved outcomes and a changing profile of biologic and anti-rheumatic drug use.  

War on RA – Part 4: Desperado – Time to Open the Gate

Do you know what the best-selling album of all time is? Could it be Bing Crosby? U2? Fleetwood Mac? AC/DC? I know, it’s Michael Jackson’s “Thriller” right? Actually it’s the Eagles Greatest Hits – it surpassed Jackson’s Thriller in August 2019 as the best-selling with a total of 36 million copies sold since it was released in 1976. Wait! Are we not Rheumatologists? Aren’t we supposed to be discussing rheumatoid arthritis?